News & Updates

Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.

Outpatients with post-COVID condition (PCC) generally tolerated exercise without significant worsening of symptoms or decline in aerobic performance after 48 hours. However, they had lower muscle strength and aerobic capacity than controls, and even showed signs of POTS* and myopathy in a randomized crossover trial.

People diagnosed with tuberculosis (TB) face a worse prognosis if they also have untreated or complicated diabetes mellitus (DM), according to a study.

Lung ultrasound (LUS), a low-cost tool with a high negative predictive value, can be a useful instrument for dismissing the presence of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA), suggests a study.

Supplementation with virgin coconut oil (VCO) helped alleviate symptoms and inflammation in individuals with COVID-19, as shown in a single-blind study.

In previously treated patients with EGFR-mutated advanced non-small-cell lung cancer (NSCLC), subcutaneous (SC) amivantamab combined with lazertinib shows noninferior pharmacokinetic and efficacy profiles compared with the approved intravenous (IV) formulation of amivantamab, according to the phase III PALOMA-3 trial.

Among smokers with chronic obstructive pulmonary disease (COPD), use of varenicline seems better than bupropion in normal metabolizers, but bupropion displays similar efficacy and less side effects in slow metabolizers, reports a study.